Efficacy and continuation rates of Norplant® in Pakistan

Contraception

Volumn 60, Issue 1, 1999, Pages 39-43

  Rehan, N ^a   Inayatullah, Attiya ^b   Chaudhary, Iffat ^b  

^a Pakistan Medical Research Council   (Pakistan)

^b Fam Plan Association of Pakistan   (Pakistan)

Author keywords

Continuation rates; Contraceptive failure; Hormonal contraception; Norplant; Pakistan; Progestin releasing implants

Indexed keywords

LEVONORGESTREL;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG IMPLANT; DRUG RELEASE; FAMILY PLANNING; FEMALE; FOLLOW UP; HORMONAL CONTRACEPTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; PAKISTAN; PREGNANCY RATE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT FAILURE;

ASIA; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTION CONTINUATION; CONTRACEPTION FAILURE; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE EFFECTIVENESS; CONTRACEPTIVE IMPLANTS; CONTRACEPTIVE METHODS; CONTRACEPTIVE USAGE; DEVELOPING COUNTRIES; FAMILY PLANNING; LEVONORGESTREL; PAKISTAN; RESEARCH METHODOLOGY; RESEARCH REPORT; SOUTHERN ASIA;

ADULT; AGE FACTORS; BODY WEIGHT; CONTRACEPTIVE AGENTS, FEMALE; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVONORGESTREL; MIDDLE AGED; PAKISTAN; PARITY; PATIENT SATISFACTION; PREGNANCY; PREGNANCY RATE;

EID: 0032700094     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(99)00054-2     Document Type: Article

References (27)

1. Segal S. The development of Norplant implants. Stud Fam Plann. 14:1993;159-162.
2. Croxatto H.B., Diaz S., Miranda P., Elamsson K., Johansson E.D. Plasma levels of levonorgestrel in women during use of Norplant. Contraception. 22:1980;583-596.
3. Roy S., Mishell D.R., Robertson D.N., Krauss R.M., Lacarra M., Duda M.J. Long-term reversible contraception with levonorgestrel-releasing Silastic rods. Am J Obstet Gynecol. 148:1984;1006-1013.
4. Sivin I., Diaz S., Holma P., Alvarez-Sanchez F., Robertson D.N. A four-year clinical study of Norplant implants. Stud Fam Plann. 14:1983;184-191.
5. Diaz S., Pavez M., Miranda P., et al. A five-year clinical trial of levonorgestrel Silastic implants (Norplant). Contraception. 25:1982;447-456.
6. Shamim N., Rehan N., Inayatullah A. Use of Norplant in Pakistan two years experience . J Pak Med Assoc. 44:1994;3-7.
7. Norplant contraceptive subdemal implants. Managerial and technical guidelines. 1991;22-97 World Health Organization, Geneva.
8. Petitti D.B. Issues in evaluating Norplant. Samuels S.E., Smith M.D. Norplant and Poor Women. 1992;65-82 The Henry J. Kaiser Family Foundation, Menlo Park, CA.
9. Affandi B., Santoso S.S.I., Djajadilaga, et al. Five-year experience with Norplant. Contraception. 36:1987;417-428.
10. Gu S., Du M., Zhang L., Liu Y., Wang S., Sivin I. A 5-year evaluation of Norplant contraceptive implant in China. Obstet Gynecol. 83:1994;673-678.
11. Chomopootaweep S., Kochagarn E., Sirisumpan S., Tangusaha J., Theppitaksak B., Dusitsin N. Effectiveness of Norplant implants among Thai women in Bangkok. Contraception. 53:1996;33-36.
12. Fisher A.A., Prinhartono J., Tuladhar J., Hoesni R.H. An assessment of Norplant removal in Indonesia. Stud Fam Plann. 28:1997;308-316.
13. Tuladhar J., Donaldson P.J., Noble J. The introduction and use of Norplant implants in Indonesia. Stud Fam Plann. 29:1998;291-299.
14. Chetri M., Bhatta A., Amatya R.N., et al. Five-year evaluation of safety, efficacy and acceptability of Norplant implants in Nepal. Advanc Contracept. 12:1996;187-199.
15. Singh K., Viegas O.A., Fong Y.F., Ratnam S.S. Acceptability of Norplant implants for fertility regulation in Singapore. Contraception. 45:1992;39-47.
16. Salah M., Ahmed A.G.M., Abo-Eloyoun M., Shaaban M.M. Five-year experience with Norplant implants in Assiut, Egypt. Contraception. 35:1987;543-550.
17. Shaaban M.M. Experience with Norplant in Egypt. Ann Med. 25:1993;167-169.
18. Sivin I. Norplant clinical trials. Samuels S.E., Smith M.D. Norplant and Poor Women. 1992;1-19 The Henry J. Kaiser Family Foundation, Menlo Park, CA.
19. Tseng L.H., Lee T.Y., Yang Y.S., Ko T.M., Chuang S.M. Norplant subdermal contraceptive system experience in Taiwan . Contraception. 53:1996;177-180.
20. Akhter H., Dunson T.R., Amatya R.N., et al. A five- year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors. Contraception. 47:1993;569-582.
21. Vekemans M., Delvigan A., Paesmans M. Continuation rates with levonorgestrel-releasing contraceptive implant (Norplant). A retrospective study in Belgium. Contraception. 56:1997;291-299.
22. Sivin I., Mishell D.R. Jr, Darney P., Wan L., Christ M. Levonorgestrel capsule implants in the United States a 5-year study . Obstet Gynecol. 92:1998;337-344.
23. Sivin I. International experience with Norplant and Norplant-2 contraception. Stud Fam Plann. 19:1988;81-94.
24. Noerpramana N.P. A cohort study of Norplant side effects and acceptance . Adv Contracept. 11:1995;97-114.
25. Cheilli H., Sfar E., Zouari F., et al. Norplant contraception at the Rabat Tunis maternity hospital. Contracept Fertil Sex (French). 22:1994;225-227.
26. Vekemans M., Delvigne A., Paesmans M. Continuity of utilisation of a levonorgestrel releasing contraceptive implant prospective study in Belgium . Rev Med Brux (French). 17:1996;375-381.
27. Norplant levonorgestrel implants a summary of scientific data . 1990;The Population Council, New York.